Molecular biological and epidemiological characteristics of the varicella-zoster virus (VZV)

被引:0
|
作者
Vanda, Bostikova [1 ]
Roman, Chlibek [1 ]
Miloslav, Salavec [2 ]
Jan, Smetana [1 ]
Radek, Sleha [1 ]
Miroslav, Splino [1 ]
Pavel, Bostik [3 ,4 ]
机构
[1] FVZ UO, Katedra Epidemiol, Hradec Kralove, Czech Republic
[2] FN & LF UK, Klin Nemoci Koznich & Pohlavnich, Hradec Kralove, Czech Republic
[3] FN & LF UK, Klin Infekcnich Nemoci, Hradec Kralove, Czech Republic
[4] FVZ UO, Centrum Pokrocilych Studii, Hradec Kralove, Czech Republic
来源
关键词
epidemiology; herpes zoster; molecular genetics; varicella-zoster virus; WILD-TYPE STRAINS; VACCINE; IDENTIFICATION; GENOTYPES;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The genetic diversity and epidemiology of VZV results from an interplay of the geographic area, climate conditions, and population factors. Studies of the genetic diversity of VZV can have direct implications for both the epidemiological and evolutionary analyses and identification of the genetic correlates of VZV pathogenicity or resistance to antiviral drugs.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [1] The molecular epidemiology of varicella-zoster virus (VZV) in Czech Republic
    Bostik, V.
    Chlibek, R.
    Salavec, M.
    Smetana, J.
    Kosina, P.
    Prasil, P.
    Plisek, S.
    Splino, M.
    Bostick, P.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E123 - E123
  • [2] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423
  • [3] Issues in varicella-zoster virus (VZV) ganglionic latency
    Kennedy, Peter G.
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 38 - 39
  • [4] Seroprevalence of varicella-zoster virus (VZV) in the French population
    Debruyne, M
    Floret, D
    Khoshnood, B
    Emery, C
    Fagnani, F
    Lancon, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S240 - S240
  • [5] SAFETY AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS (VZV) VACCINE IN ADULTS
    KUMAR, ML
    COLLINS, MS
    GOPALAKRISHNA, KV
    [J]. PEDIATRIC RESEARCH, 1986, 20 (04) : A313 - A313
  • [6] DEFICIENT VARICELLA-ZOSTER VIRUS (VZV) SPECIFIC IMMUNITY IN THE ELDERLY
    KIRMANI, N
    ANGELINO, J
    [J]. CLINICAL RESEARCH, 1992, 40 (03): : A717 - A717
  • [7] ANTIBODY-RESPONSES TO EARLY ANTIGENS OF VARICELLA-ZOSTER VIRUS (VZV) DURING VARICELLA AND ZOSTER
    NAMAZUE, J
    KATO, T
    YAMANISHI, K
    TAKAHASHI, M
    ASANO, Y
    MURAKI, R
    [J]. BIKEN JOURNAL, 1986, 29 (3-4) : 91 - 97
  • [8] Varicella-Zoster Virus (VZV) Reactivation Resulted in Myelitis and Stroke
    Zhou, Yongxing
    Anand, Abhishek
    Temesgen, Frehiwot
    Najibi, Faranak
    Weir, Roger
    Dunlap, Shariff
    Trouth, Annapurni Jayam
    [J]. ANNALS OF NEUROLOGY, 2015, 78 : S90 - S90
  • [9] POLYPEPTIDES OF VARICELLA-ZOSTER VIRUS (VZV) AND IMMUNOLOGICAL RELATIONSHIP OF VZV AND HERPES-SIMPLEX VIRUS (HSV)
    SHIRAKI, K
    OKUNO, T
    YAMANISHI, K
    TAKAHASHI, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1982, 61 (AUG): : 255 - 269
  • [10] VARICELLA-ZOSTER VIRUS (VZV) INFECTION FOLLOWING RENAL-TRANSPLANTATION
    STEVENS, ME
    HILLIS, AN
    HART, A
    BONE, JM
    [J]. KIDNEY INTERNATIONAL, 1984, 26 (04) : 655 - 655